Polynovo (ASX:PNV) share price bounces off 10-month lows, up 3% today

July has not been kind to Polynovo shareholders.
The post Polynovo (ASX:PNV) share price bounces off 10-month lows, up 3% today appeared first on The Motley Fool Australia. –

The Polynovo Ltd (ASX: PNV) share price is catching a break today after sliding as much as 26.95% in July.

At the time of writing, shares in the medical devices company are up 2.67% to $2.11.

Polynovo stumbles to a 10-month low

2021 is shaping up to be a miserable year for Polynovo shareholders, with the company’s shares down 46% year-to-date.

The Polynovo share price began struggling in January when the company’s shares tumbled 32% following a disappointing half-year trading update.

The update looked good at face value, highlighting a 31% increase in 1H21 sales against the prior corresponding period.

However, back in November 2020, management said that “we continue to harness this [FY20] momentum to double our revenues again in FY21”.

With an underpromise and overdeliver narrative taking place, brokers were also quick to flag disappointing results that were “well below our forecasts, consensus and management expectations”.

Last Tuesday, Polynovo released a fourth quarter and FY21 market update.

The initial market reaction was positive, with the Polynovo share price rallying 4.62% to $2.49 on the day.

However, over the next three sessions, Polynovo shares would slide 17.27% to a close of $2.06 last Friday.

Bell Potter was quick to criticise Polynovo’s fourth quarter and FY21 update, saying: “Today’s announcement came as a 13% miss vs our expectations – we expected COVID recovery tailwinds would make an impact on sales in the 2H.”

Broader healthcare gains lift the Polynovo share price on Monday

Despite a sea of red for the S&P/ASX 200 Index (ASX: XJO), the healthcare sector is picking up the slack with gains across the board.

There has been broad buying across the healthcare sector, with names including CSL Ltd (ASX: CSL), Sonic Healthcare Ltd (ASX: SHL) and Resmed CDI (ASX: RMD) rallying 2.34%, 1.61% and 2.64% respectively.

While the Polynovo share price has joined in on the rally today, it has a lot of catching up to do.

The post Polynovo (ASX:PNV) share price bounces off 10-month lows, up 3% today appeared first on The Motley Fool Australia.

Should you invest $1,000 in Polynovo right now?

Before you consider Polynovo , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Polynovo wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of May 24th 2021

More reading

I’m investing for my kids. Any advice?

These ASX 200 healthcare shares are holding up in today’s sea of red

Why is the Temple & Webster (ASX:TPW) share price up over 3% today?
Why CSL, Humm, IntelliHR, & Vulcan shares are pushing higher

Why the Sonic Healthcare (ASX:SHL) share price hit an all-time high today

Motley Fool contributor Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended CSL Ltd. and POLYNOVO FPO. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has recommended ResMed Inc. and Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!